Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature

@inproceedings{Tsavaris2018ClinicalBO,
  title={Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature},
  author={Onoufrios Tsavaris and Panagiota Economopoulou and Ioannis K Kotsantis and Lazaros Reppas and Chrysanthi Avgerinou and Nikolaos Spathas and Maria Prevezanou and Amanda Psyrri},
  booktitle={Front. Oncol.},
  year={2018}
}
Chondrosarcoma is a rare malignancy characterized by the production of cartilage matrix, displaying heterogeneous histopathology and clinical behavior. Due to lack of effective treatment for advanced disease, the clinical management of metastatic chondrosarcoma is exceptionally challenging. Chondrosarcomas harbor molecular abnormalities, such as… CONTINUE READING